| N (%) | OR | 95%CI | aOR | 95%CI |
---|---|---|---|---|---|
CD4 (per mm3) (Screening Visit) | |||||
  ≥ 500 (ref) | 111 (47.2) | 1 | – | 1 | – |
 350–499 | 49 (20.9 | 1.43 | 0.73–2.81 | 1.46 | 0.67–3.15 |
 200–349 | 39 (16.6) | 1.64 | 0.78–3.42 | 1.56 | 0.69–3.51 |
  < 200 | 23 (9.8) | 2.37 | 0.93–6.05 | 2.48 | 0.84–7.35 |
 Missing | 13 (5.5) | 1.08 | 0.34–3.44 | 2.19 | 0.57–8.41 |
ptrenda= | Â | 0.04 | 0.06 | ||
Detectable HIV Viral Load (Screening Visit) | |||||
 No (ref) | 183 (77.9) | 1 | – | 1 | – |
 Yes | 27 (11.5) | 1.99 | 0.84–4.63 | 1.75 | 0.67–4.57 |
 Missing | 25 (10.6) | 0.47 | 0.19–1.13 | 0.34 | 0.12–0.98 |
Age Group (years) (Screening Visit) | |||||
 30–33 (ref) | 54 (23.0) | 1 | – | 1 | – |
 34–36 | 53 (22.6) | 1.5 | 0.70–3.23 | 1.74 | 0.74–4.08 |
 37–42 | 63 (26.8) | 1.1 | 0.52–2.25 | 0.80 | 0.34–1.83 |
 43–54 | 65 (27.7) | 2.0 | 0.97–4.21 | 2.26 | 1.01–5.05 |
ptrend= | Â | 0.13 | 0.17 | ||
Follow-Up Time (Days) | |||||
 197–490 (ref) | 66 (28.1) | 1 | – | 1 | – |
 490–649 | 62 (26.4) | 0.38 | 0.29–0.79 | 0.35 | 0.16–0.77 |
 650–820 | 49 (20.9) | 0.89 | 0.43–1.86 | 0.94 | 0.41–2.14 |
 821–1161 | 52 (22.1) | 0.68 | 0.32–1.41 | 0.74 | 0.33–1.67 |
 Missing | 6 (2.6) | 0.34 | 0.06–1.97 | 0.61 | 0.08–4.59 |
ptrenda= | Â | 0.68 | 0.93 | ||
Colposcopic Impression | |||||
 low-grade (ref) | 207 (88.1) | 1 | – | 1 | – |
 high-grade | 21 (8.9) | 23.1 | 3.0–175.52 | 24.90 | 3.08–201.22 |
 Missing | 7 (3.0) | 0.86 | 0.66–1.14 | 0.33 | 0.05–2.11 |
Number of hrHPV Types Detected at the Screening Visit | |||||
 1 (ref) | 133 (56.6) | 1 | – |  |  |
  ≥ 2 | 102 (43.4) | 0.99 | 0.59–1.66 |  |  |